Revolution Medicines
Price & Volume
Stats
See more52W Range | $34-$193.09 |
Market Cap | $39.8B |
Shares Short | 12M |
Financials
See moreRevenue (12 Mos) | $742,000 |
Revenue Growth (YoY) | -95.2% |
Gross Profit (12 Mos) | -$1.1B |
Diluted EPS | -$7.12 |
News
See moreYahoo Finance • 2 days ago
Revolution Medicines Has a $40 Billion Market Cap and Generates No Revenue. Here's Why That's Not Absurd.
Yahoo Finance • 3 days ago
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Erasca, Inc. of Class Action Lawsuit and Upcoming Deadlines – ERAS
Yahoo Finance • 10 days ago
After Apogee, 3 More Biotech Buyout Targets Wall Street Can’t Stop Watching
Yahoo Finance • 17 days ago
SCHA vs. ISCB: Which Small-Cap ETF Is the Better Buy for Investors in 2026?
About
CEO | Dr. Mark A. Goldsmith M.D., Ph.D. |
Address | 700 Saginaw Drive, Redwood City, CA, United States, 94063 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 883 |